Swiss Life Sciences Stock News

As we step into 2026, the European market is riding a wave of optimism, with the STOXX Europe 600 Index reaching new highs and closing out 2025 with its strongest annual performance since 2021. This buoyant economic backdrop provides fertile ground for growth companies, especially those with high insider ownership, as they often align management interests closely with shareholder value—an appealing trait in today's market environment.

If you are wondering whether Novartis shares are still reasonably priced or already baking in a lot of good news, you are in the right place. The stock last closed at US$113.76, with returns of 3.8% over 7 days, 6.5% over 30 days, 4.8% year to date, 28.6% over 1 year, 59.9% over 3 years and 74.2% over 5 years. This performance has caught the attention of many long term holders and potential new investors. Recent news around Novartis has focused on ongoing product pipeline updates and...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Valartis Group AG's ( VTX:VLRT ) price-to-earnings (or "P/E") ratio of 3.5x might make it look like a strong buy right...

Shareholders in Bergbahnen Engelberg-Trübsee-Titlis AG ( VTX:TIBN ) may be thrilled to learn that the covering analyst...

MCH Group AG ( VTX:MCHN ) shareholders would be excited to see that the share price has had a great month, posting a...

MCH Group AG ( VTX:MCHN ) shareholders would be excited to see that the share price has had a great month, posting a...

While it may not be enough for some shareholders, we think it is good to see the Barry Callebaut AG ( VTX:BARN ) share...

Nestlé recently recalled several batches of its SMA infant and follow-on formula in the UK after tests indicated potential cereulide toxin contamination, although no related illnesses have been confirmed to date. This incident puts a spotlight on Nestlé’s infant nutrition quality controls and brand trust, especially in a category where safety perceptions are critical. We’ll now examine how this precautionary SMA formula recall, and its implications for consumer trust, may influence Nestlé’s...

Wondering whether Alcon’s current share price gives you fair value for your money, or if you are paying up for quality? This article breaks down what the numbers are actually saying about the stock. The shares recently closed at $64.64, with returns of 2.1% over the past week, 0.6% over the past month, 1.7% year to date, and a 15.0% decline over the last year, putting recent moves into a longer term context. These mixed returns have sharpened the focus on what is really priced into Alcon...

One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger...

Key Insights Georg Fischer's significant individual investors ownership suggests that the key decisions are influenced...

Novartis (SWX:NOVN) shares have quietly moved higher over the past month and past 3 months, putting recent performance and current valuation metrics in focus for investors watching this large Swiss pharmaceutical group. See our latest analysis for Novartis. Zooming out, the share price is at CHF 111.52 with a 1 year total shareholder return of 27.79% and a 5 year total shareholder return of 71.01%, suggesting momentum has been building rather than fading over time. If Novartis has you...

Nestlé (SWX:NESN) is back in focus after recent share price moves, with the stock showing mixed short term returns and a modestly positive performance over the past 3 months, prompting fresh questions about how its current valuation stacks up. See our latest analysis for Nestlé. At a share price of CHF 76.16, Nestlé’s short term share price returns have been weak, while its 1 year total shareholder return of 5.3% contrasts with deeper three and five year total return declines. This points to...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

European markets have shown robust performance, with the pan-European STOXX Europe 600 Index reaching a new high and closing 2025 with its strongest annual return since 2021. For investors interested in smaller or newer companies, penny stocks—despite their somewhat outdated name—remain a relevant investment area. These stocks can offer surprising value when backed by strong financials, presenting opportunities for growth that larger firms might miss.

Key Insights The considerable ownership by private companies in Cosmo Pharmaceuticals indicates that they collectively...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Mobimo Holding AG recently placed a CHF 155 million green bond on the Swiss capital market under its new Green Financing Framework, with listing on the Swiss Exchange planned from 28 January 2026. The bond, backed by a positive Second Party Opinion from Moody’s Ratings for alignment with international green finance principles, highlights Mobimo’s growing appeal to environmentally focused investors in the Swiss real estate space. Next, we’ll explore how this Moody’s-endorsed Green Financing...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

It's easy to match the overall market return by buying an index fund. But if you buy individual stocks, you can do both...

Key Insights The projected fair value for Dätwyler Holding is CHF125 based on 2 Stage Free Cash Flow to Equity Current...